Gut hyperpermiability after ischemia and reperfusion: attenuation with adrenomedullin and its binding protein treatment.
Ischemia bowel remains a critical problem resulting in up to 80% mortality. The loss of gut barrier function plays an important role. Our previous studies have shown that administration of adrenomedullin (AM), a novel vasoactive peptide, and its binding protein (AMBP-1), reduces the systemic inflammatory response and organ injury after systemic ischemia induced by hemorrhagic shock. However, it remains unknown whether administration of AM/AMBP-1 preserves gut barrier function after gut ischemia reperfusion (I/R). We therefore hypothesized that AM/AMBP-1 prevents structural and functional damages to the intestinal mucosa after gut I/R. To test this, gut ischemia was induced by placing a microvascular clip across the superior mesenteric artery (SMA) for 90 min in male adult rats. After release of the SMA clamp, AM (12 mug/kg BW) and AMBP-1 (40 mug/kg BW) in combination or vehicle (1-ml normal saline) were administered intravenously over a period of 30 min. The mucosal barrier function in the small intestine was assessed in an isolated everted ileum sac using fluorescein-isothiocyanate dextran (FD4) at 4 h after AM/AMBP-1 treatment. FD4 clearance was used as a measure of gut permeability. In additional groups of animals, blood and small intestine samples were collected at 4 h after the treatment. Morphological changes in the small intestine were assessed by H-E staining. Serum concentrations of alanine aminotransferase, aspartate aminotransferase, total bilirubin, direct bilirubin, lactate and lactate dehydrogenase were also assessed. The gene expression and protein levels of TNF-alpha in the small intestine were determined by RT-PCR and ELISA, respectively. Our results showed that administration of AM/AMBP-1 significantly attenuated the development of intestinal mucosal hyperpermeability during the reperfusion. Treatment with AM/AMBP-1 dramatically improved I/R-induced intestinal mucosal damages, attenuated remote organ injury, and downregulated gene expression and protein levels of TNF-alpha in the small intestine. In conclusion, AM/AMBP-1 attenuates structural and functional damages to the intestinal mucosa, and it appears to be a novel treatment for reperfusion injury after gut ischemia. The beneficial effect of AM/AMBP-1 on gut barrier function after I/R is associated with downregulation of TNF-alpha.
Higuchi
Shinya
S
Department of Surgery, North Shore University Hospital, NY, USA.
Wu
Rongqian
R
Zhou
Mian
M
Marini
Corrado P
CP
Ravikumar
Thanjavur S
TS
Wang
Ping
P
Biochem Biophys Res Commun. 1993 Apr 30;192(2):553-60
8387282
Ann Surg. 2002 Nov;236(5):625-33
12409669
Shock. 2005 Apr;23(4):330-6
15803056
Am J Respir Crit Care Med. 1998 Aug;158(2):444-51
9700119
Am J Gastroenterol. 1983 Sep;78(9):537-47
6613965
Am J Pathol. 2002 Aug;161(2):373-9
12163361
Arch Surg. 1970 Oct;101(4):478-83
5457245
Crit Care Med. 1999 Oct;27(10):2246-51
10548215
Shock. 1999 Aug;12(2):127-33
10446893
Crit Care Med. 1995 Jul;23(7):1170-6
7541323
Am J Physiol Regul Integr Comp Physiol. 2002 Sep;283(3):R553-60
12184987
J Immunol. 1993 Mar 15;150(6):2356-63
8450217
Crit Care Med. 2002 Dec;30(12):2729-35
12483065
Annu Rev Physiol. 1999;61:363-89
10099693
Biochem Biophys Res Commun. 1995 Jun 26;211(3):1031-5
7598689
Chest. 1997 Aug;112(2):491-5
9266889
Am J Physiol Gastrointest Liver Physiol. 2005 Mar;288(3):G422-30
15701621
J Biol Chem. 2001 Apr 13;276(15):12292-300
11116141
J Trauma. 2005 May;58(5):995-1001
15920415
Shock. 2006 Dec;26(6):620-4
17117139
Eur J Immunol. 1991 Apr;21(4):967-72
1826890
Regul Pept. 2003 Apr 15;112(1-3):19-26
12667621
Mol Immunol. 1980 Jan;17(1):9-20
7360115
Surgery. 2005 Feb;137(2):200-8
15674202
Mol Med. 2006 Apr-Jun;12(4-6):105-14
16953558
Eur J Surg. 2001 Apr;167(4):299-304
11354324
Am J Physiol Gastrointest Liver Physiol. 2006 Mar;290(3):G496-504
16474009
Crit Care Med. 2005 Feb;33(2):391-8
15699844
J Trauma. 1998 Jun;44(6):1031-5; discussion 1035-6
9637159
J Gastrointest Surg. 1999 May-Jun;3(3):252-62
10481118
J Am Coll Surg. 2007 Aug;205(2):284-93
17660075
J Immunol. 1998 Apr 15;160(8):4057-66
9558116
Shock. 2000 Aug;14(2):134-41
10947156
Endocrinology. 1997 Jun;138(6):2615-20
9165056
JPEN J Parenter Enteral Nutr. 1985 Sep-Oct;9(5):608-17
3900455
Arch Intern Med. 2004 May 24;164(10):1054-62
15159262
Respir Care Clin N Am. 1998 Dec;4(4):611-31, vii-viii
9881396
World J Surg. 1996 May;20(4):411-7
8662128
Shock. 2004 Jan;21(1):65-71
14676686
Ann Surg. 2005 Jul;242(1):115-23
15973109